HIV-1 entry, inhibitors, and resistance

40Citations
Citations of this article
107Readers
Mendeley users who have this article in their library.

Abstract

Entry inhibitors represent a new class of antiretroviral agents for the treatment of infection with HIV-1. While resistance to other HIV drug classes has been well described, resistance to this new class is still ill defined despite considerable clinical use. Several potential mechanisms have been proposed: tropism switching (utilization of CXCR4 instead of CCR5 for entry), increased affinity for the coreceptor, increased rate of virus entry into host cells, and utilization of inhibitor-bound receptor for entry. In this review we will address the development of attachment, fusion, and coreceptor entry inhibitors and explore recent studies describing potential mechanisms of resistance. © 2010 by the authors.

Cite

CITATION STYLE

APA

Lobritz, M. A., Ratcliff, A. N., & Arts, E. J. (2010, May). HIV-1 entry, inhibitors, and resistance. Viruses. https://doi.org/10.3390/v2051069

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free